+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Global Preventive Vaccines Market 2020-2026 by Vaccine Type, Disease, Administration, Patient, and Region: COVID-19 Impact and Growth Opportunity

  • ID: 5206696
  • Report
  • May 2021
  • Region: Global
  • 207 Pages
  • GMD Research

FEATURED COMPANIES

  • AstraZeneca plc
  • Bavarian Nordic A/S
  • CSL Ltd.
  • Daiichi Sankyo Co. Ltd
  • GlaxoSmithKline plc
  • Johnson & Johnson
Global preventive vaccines market will reach $80.47 billion by 2026, growing by 11.26% annually over 2020-2026 owing to increasing healthcare expenditure, new development of the vaccines, and rising need for preventive vaccines especially new COVID-19 vaccines.



Highlighted with 110 tables and 84 figures, this 207-page report “Global Preventive Vaccines Market 2020-2026 by Vaccine Type, Disease, Administration, Patient, and Region: COVID-19 Impact and Growth Opportunity” is based on a holistic research of the entire global preventive vaccines market and all its sub-segments through extensively detailed classifications. Profound analysis and assessment are generated from premium primary and secondary information sources with inputs derived from industry professionals across the value chain. The report is based on studies on 2016-2019 and provides estimate/forecast from 2020 till 2026 with 2019 as the base year.

In-depth qualitative analyses include identification and investigation of the following aspects:
  • Market Structure
  • Growth Drivers
  • Restraints and Challenges
  • Emerging Product Trends & Market Opportunities
  • Porter’s Fiver Forces

The trend and outlook of global market is forecast in optimistic, balanced, and conservative view by taking into account of COVID-19. The balanced (most likely) projection is used to quantify global preventive vaccines market in every aspect of the classification from perspectives of Vaccine Type, Disease, Administration, Patient, and Region.

Based on Vaccine Type, the global market is segmented into the following sub-markets with annual revenue ($ mn) for 2016-2026 included in each section.
  • Live/Attenuated Vaccines
  • Inactivated Vaccines
  • Subunit Vaccines
  • Toxoid Vaccines
  • Conjugate Vaccines
  • Recombinant Vector Vaccines
  • Other Vaccines

Based on Disease, the global market is segmented into the following sub-markets with annual revenue ($ mn) for 2016-2026 included in each section.
  • Vaccines for Pneumococcal Disease
  • Vaccines for Poliovirus
  • Vaccines for Hepatitis
  • Vaccines for Influenza
  • Vaccines for Measles, Mumps, and Rubella (MMR)
  • Vaccines for Varicella
  • Vaccines for Human Papilloma Virus
  • Vaccines for COVID-19
  • Vaccines for Other Diseases

Based on Administration, the global market is segmented into the following sub-markets with annual revenue ($ mn) for 2016-2026 included in each section.
  • Intramuscular Route
  • Subcutaneous Route
  • Oral Route
  • Intravenous Injection
  • Other Administration Routes

Based on Patient, the global market is segmented into the following sub-markets with annual revenue ($ mn) for 2016-2026 included in each section.
  • Pediatric Vaccines
  • Pneumococcal
  • Measles, Mumps, and Rubella (MMR)
  • Varicella
  • Hepatitis
  • Poliovirus
  • Haemophilus Influenzae B (HIB)
  • Other Diseases
  • Adult Vaccines
  • Influenza
  • Cervical Cancer
  • Hepatitis
  • Zoster
  • Other Diseases

Geographically, the following regions together with the listed national/local markets are fully investigated:
  • APAC (Japan, China, South Korea, Australia, India, and Rest of APAC; Rest of APAC is further segmented into Malaysia, Singapore, Indonesia, Thailand, New Zealand, Vietnam, Taiwan, and Philippines)
  • Europe (Germany, UK, France, Spain, Italy, Russia, Rest of Europe; Rest of Europe is further segmented into Netherlands, Switzerland, Poland, Sweden, Belgium, Austria, Ireland, Norway, Denmark, and Finland)
  • North America (U.S., Canada, and Mexico)
  • South America (Brazil, Colombia, Argentina, Rest of South America)
  • MEA (Saudi Arabia, UAE, Egypt)

For each region and key country, detailed analysis and data for annual revenue ($ mn) are available for 2016-2026. The breakdown of all regional markets by country and split of key national markets by Vaccine Type, Disease, and Route of Administration over the forecast years are also included.

The report also covers current competitive scenario and the predicted trend; and profiles key vendors including market leaders and important emerging players.

Specifically, potential risks associated with investing in global preventive vaccines market are assayed quantitatively and qualitatively through GMD’s Risk Assessment System. According to the risk analysis and evaluation, Critical Success Factors (CSFs) are generated as a guidance to help investors & stockholders identify emerging opportunities, manage and minimize the risks, develop appropriate business models, and make wise strategies and decisions.

Key Players (this may not be a complete list and extra companies can be added upon request):
  • AstraZeneca plc
  • Bavarian Nordic A/S
  • China National Biotec Group Company Ltd.
  • CSL Ltd.
  • Daiichi Sankyo Co. Ltd
  • Emergent BioSolutions Inc.
  • GlaxoSmithKline plc
  • Johnson & Johnson
  • Merck & Co.
  • Moderna Inc.
  • Novavax, Inc.
  • Pfizer Inc.
  • Sanofi SA
  • Takeda Pharmaceutical Co. Ltd.

(Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.)
Frequently Asked Questions about the Global Preventive Vaccines Market

What is the estimated value of the Global Preventive Vaccines Market?

The Global Preventive Vaccines Market was estimated to be valued at $42430.4 Million in 2020.

What is the growth rate of the Global Preventive Vaccines Market?

The growth rate of the Global Preventive Vaccines Market is 11.2%, with an estimated value of $80473.5 Million by 2026.

What is the forecasted size of the Global Preventive Vaccines Market?

The Global Preventive Vaccines Market is estimated to be worth $80473.5 Million by 2026.

Who are the key companies in the Global Preventive Vaccines Market?

Key companies in the Global Preventive Vaccines Market include AstraZeneca plc, Bavarian Nordic A/S, China National Biotec Group Company Ltd., CSL Ltd., Daiichi Sankyo Co. Ltd, Emergent BioSolutions Inc., GlaxoSmithKline plc, Johnson & Johnson and Moderna Inc..
Note: Product cover images may vary from those shown

FEATURED COMPANIES

  • AstraZeneca plc
  • Bavarian Nordic A/S
  • CSL Ltd.
  • Daiichi Sankyo Co. Ltd
  • GlaxoSmithKline plc
  • Johnson & Johnson

1 Introduction
1.1 Industry Definition and Research Scope
1.1.1 Industry Definition
1.1.2 Research Scope
1.2 Research Methodology
1.2.1 Overview of Market Research Methodology
1.2.2 Market Assumption
1.2.3 Secondary Data
1.2.4 Primary Data
1.2.5 Data Filtration and Model Design
1.2.6 Market Size/Share Estimation
1.2.7 Research Limitations
1.3 Executive Summary
2 Market Overview and Dynamics
2.1 Market Size and Forecast
2.1.1 Impact of COVID-19 on World Economy
2.1.2 Impact of COVID-19 on the Market
2.2 Major Growth Drivers
2.3 Market Restraints and Challenges
2.4 Emerging Opportunities and Market Trends
2.5 Porter’s Five Forces Analysis
3 Segmentation of Global Market by Vaccine Type
3.1 Market Overview by Vaccine Type
3.2 Live/Attenuated Vaccines
3.3 Inactivated Vaccines
3.4 Subunit Vaccines
3.5 Toxoid Vaccines
3.6 Conjugate Vaccines
3.7 Recombinant Vector Vaccines
3.8 Other Vaccines
4 Segmentation of Global Market by Disease
4.1 Market Overview by Disease
4.2 Vaccines for Pneumococcal Disease
4.3 Vaccines for Poliovirus
4.4 Vaccines for Hepatitis
4.5 Vaccines for Influenza
4.6 Vaccines for Measles, Mumps, and Rubella (MMR)
4.7 Vaccines for Varicella
4.8 Vaccines for Human Papilloma Virus
4.9 Vaccines for COVID-19
4.10 Vaccines for Other Diseases
5 Segmentation of Global Market by Administration
5.1 Market Overview by Administration
5.2 Intramuscular Route
5.3 Subcutaneous Route
5.4 Oral Route
5.5 Intravenous Injection
5.6 Other Administration Routes
6 Segmentation of Global Market by Patient
6.1 Market Overview by Patient
6.2 Pediatric Vaccines
6.3 Adult Vaccines
7 Segmentation of Global Market by Region
7.1 Geographic Market Overview 2020-2026
7.2 North America Market 2020-2026 by Country
7.2.1 Overview of North America Market
7.2.2 U.S.
7.2.3 Canada
7.2.4 Mexico
7.3 European Market 2020-2026 by Country
7.3.1 Overview of European Market
7.3.2 UK
7.3.3 France
7.3.4 Germany
7.3.5 Spain
7.3.6 Italy
7.3.7 Russia
7.3.8 Rest of European Market
7.4 Asia-Pacific Market 2020-2026 by Country
7.4.1 Overview of Asia-Pacific Market
7.4.2 China
7.4.3 Japan
7.4.4 India
7.4.5 Australia
7.4.6 South Korea
7.4.7 Rest of APAC Region
7.5 South America Market 2020-2026 by Country
7.5.1 Argentina
7.5.2 Brazil
7.5.3 Colombia
7.5.4 Rest of South America Market
7.6 MEA Market 2020-2026 by Country
7.6.1 UAE
7.6.2 Saudi Arabia
7.6.3 Egypt
7.6.4 Other National Markets
8 Competitive Landscape
8.1 Overview of Key Vendors
8.2 New Product Launch, Partnership, Investment, and M&A
8.3 Company Profiles
  • AstraZeneca plc
  • Bavarian Nordic A/S
  • China National Biotec Group Company Ltd.
  • CSL Ltd.
  • Daiichi Sankyo Co. Ltd
  • Emergent BioSolutions Inc.
  • GlaxoSmithKline plc
  • Johnson & Johnson
  • Merck & Co.
  • Moderna Inc.
  • Novavax, Inc.
  • Pfizer Inc.
  • Sanofi SA
  • Takeda Pharmaceutical Co. Ltd.

9 Investing in Global Market: Risk Assessment and Management
9.1 Risk Evaluation of Global Market
9.2 Critical Success Factors (CSFs)
List of Tables
Table 1. Snapshot of Global Preventive Vaccines Market in Balanced Perspective, 2020-2026
Table 2. Growth Rate of World GDP, 2020-2022
Table 3. Main Product Trends and Market Opportunities in Global Preventive Vaccines Market
Table 4. Global Preventive Vaccines Market by Vaccine Type, 2016-2026, $ mn
Table 5. Global Preventive Vaccines Market by Disease, 2016-2026, $ mn
Table 6. COVID-19 Vaccines Authorized for Emergency Use or Approved for Full Use, as of April 2021
Table 7. Global Preventive Vaccines Market by Administration, 2016-2026, $ mn
Table 8. Global Preventive Vaccines Market by Patient, 2016-2026, $ mn
Table 9. Global Preventive Vaccines Market: Pediatric Vaccines by Disease, 2016-2026, $ mn
Table 10. Global Preventive Vaccines Market: Adult Vaccines by Disease, 2016-2026, $ mn
Table 11. Global Preventive Vaccines Market by Region, 2016-2026, $ mn
Table 12. Leading National Preventive Vaccines Market, 2020 and 2026, $ mn
Table 13. North America Preventive Vaccines Market by Country, 2016-2026, $ mn
Table 14. U.S. Preventive Vaccines Market by Vaccine Type, 2016-2026, $ mn
Table 15. U.S. Preventive Vaccines Market by Disease, 2016-2026, $ mn
Table 16. U.S. Preventive Vaccines Market by Administration, 2016-2026, $ mn
Table 17. Canada Preventive Vaccines Market by Vaccine Type, 2016-2026, $ mn
Table 18. Canada Preventive Vaccines Market by Disease, 2016-2026, $ mn
Table 19. Canada Preventive Vaccines Market by Administration, 2016-2026, $ mn
Table 20. Mexico Preventive Vaccines Market by Vaccine Type, 2016-2026, $ mn
Table 21. Mexico Preventive Vaccines Market by Disease, 2016-2026, $ mn
Table 22. Mexico Preventive Vaccines Market by Administration, 2016-2026, $ mn
Table 23. Europe Preventive Vaccines Market by Country, 2016-2026, $ mn
Table 24. UK Preventive Vaccines Market by Vaccine Type, 2016-2026, $ mn
Table 25. UK Preventive Vaccines Market by Disease, 2016-2026, $ mn
Table 26. UK Preventive Vaccines Market by Administration, 2016-2026, $ mn
Table 27. France Preventive Vaccines Market by Vaccine Type, 2016-2026, $ mn
Table 28. France Preventive Vaccines Market by Disease, 2016-2026, $ mn
Table 29. France Preventive Vaccines Market by Administration, 2016-2026, $ mn
Table 30. Germany Preventive Vaccines Market by Vaccine Type, 2016-2026, $ mn
Table 31. Germany Preventive Vaccines Market by Disease, 2016-2026, $ mn
Table 32. Germany Preventive Vaccines Market by Administration, 2016-2026, $ mn
Table 33. Spain Preventive Vaccines Market by Vaccine Type, 2016-2026, $ mn
Table 34. Spain Preventive Vaccines Market by Disease, 2016-2026, $ mn
Table 35. Spain Preventive Vaccines Market by Administration, 2016-2026, $ mn
Table 36. Italy Preventive Vaccines Market by Vaccine Type, 2016-2026, $ mn
Table 37. Italy Preventive Vaccines Market by Disease, 2016-2026, $ mn
Table 38. Italy Preventive Vaccines Market by Administration, 2016-2026, $ mn
Table 39. Russia Preventive Vaccines Market by Vaccine Type, 2016-2026, $ mn
Table 40. Germany Preventive Vaccines Market by Disease, 2016-2026, $ mn
Table 41. Germany Preventive Vaccines Market by Administration, 2016-2026, $ mn
Table 42. Preventive Vaccines Market in Rest of Europe by Country, 2016-2026, $ mn
Table 43. APAC Preventive Vaccines Market by Country, 2016-2026, $ mn
Table 44. China Preventive Vaccines Market by Vaccine Type, 2016-2026, $ mn
Table 45. China Preventive Vaccines Market by Disease, 2016-2026, $ mn
Table 46. China Preventive Vaccines Market by Administration, 2016-2026, $ mn
Table 47. Japan Preventive Vaccines Market by Vaccine Type, 2016-2026, $ mn
Table 48. Japan Preventive Vaccines Market by Disease, 2016-2026, $ mn
Table 49. Japan Preventive Vaccines Market by Administration, 2016-2026, $ mn
Table 50. India Preventive Vaccines Market by Vaccine Type, 2016-2026, $ mn
Table 51. India Preventive Vaccines Market by Disease, 2016-2026, $ mn
Table 52. India Preventive Vaccines Market by C Administration, 2016-2026, $ mn
Table 53. Australia Preventive Vaccines Market by Vaccine Type, 2016-2026, $ mn
Table 54. Australia Preventive Vaccines Market by Disease, 2016-2026, $ mn
Table 55. Australia Preventive Vaccines Market by Administration, 2016-2026, $ mn
Table 56. South Korea Preventive Vaccines Market by Vaccine Type, 2016-2026, $ mn
Table 57. South Korea Preventive Vaccines Market by Disease, 2016-2026, $ mn
Table 58. South Korea Preventive Vaccines Market by Administration, 2016-2026, $ mn
Table 59. Preventive Vaccines Market in Rest of APAC by Country, 2016-2026, $ mn
Table 60. South America Preventive Vaccines Market by Country, 2016-2026, $ mn
Table 61. Argentina Preventive Vaccines Market by Vaccine Type, 2016-2026, $ mn
Table 62. Argentina Preventive Vaccines Market by Disease, 2016-2026, $ mn
Table 63. Argentina Preventive Vaccines Market by Administration, 2016-2026, $ mn
Table 64. Brazil Preventive Vaccines Market by Vaccine Type, 2016-2026, $ mn
Table 65. Brazil Preventive Vaccines Market by Disease, 2016-2026, $ mn
Table 66. Brazil Preventive Vaccines Market by Administration, 2016-2026, $ mn
Table 67. Colombia Preventive Vaccines Market by Vaccine Type, 2016-2026, $ mn
Table 68. Mexico Preventive Vaccines Market by Disease, 2016-2026, $ mn
Table 69. Mexico Preventive Vaccines Market by Administration, 2016-2026, $ mn
Table 70. MEA Preventive Vaccines Market by Country, 2016-2026, $ mn
Table 71. UAE Preventive Vaccines Market by Vaccine Type, 2016-2026, $ mn
Table 72. UAE Preventive Vaccines Market by Disease, 2016-2026, $ mn
Table 73. UAE Preventive Vaccines Market by Administration, 2016-2026, $ mn
Table 74. Saudi Arabia Preventive Vaccines Market by Vaccine Type, 2016-2026, $ mn
Table 75. Saudi Arabia Preventive Vaccines Market by Disease, 2016-2026, $ mn
Table 76. Saudi Arabia Preventive Vaccines Market by Administration, 2016-2026, $ mn
Table 77. Egypt Preventive Vaccines Market by Vaccine Type, 2016-2026, $ mn
Table 78. Egypt Preventive Vaccines Market by Disease, 2016-2026, $ mn
Table 79. Egypt Preventive Vaccines Market by Administration, 2016-2026, $ mn
Table 80. AstraZeneca plc: Company Snapshot
Table 81. AstraZeneca plc: Revenue, 2018-2020, $ bn
Table 82. Bavarian Nordic A/S: Company Snapshot
Table 83. Bavarian Nordic A/S: Marketed Products and Pipeline, as of July 2020
Table 84. China National Biotec Group Company Ltd.: Company Snapshot
Table 85. CSL Ltd.: Company Snapshot
Table 86. Daiichi Sankyo Co. Ltd.: Company Snapshot
Table 87. Emergent BioSolutions Inc.: Company Snapshot
Table 88. GlaxoSmithKline: Company Snapshot
Table 89. GlaxoSmithKline: Business Segmentation
Table 90. GlaxoSmithKline: Product Portfolio
Table 91. GlaxoSmithKline: Revenue, 2018-2020, $ bn
Table 92. GlaxoSmithKline: Recent Developments
Table 93. Johnson & Johnson: Company Snapshot
Table 94. Johnson & Johnson: Business Segments
Table 95. Merck & Co., Inc.: Company Snapshot
Table 96. Merck & Co., Inc.: Business Segmentation
Table 97. Merck & Co., Inc.: Revenue, 2018-2020, $ bn
Table 98. Moderna Inc.: Company Snapshot
Table 99. Novavax, Inc.: Company Snapshot
Table 100. Pfizer Inc.: Company Snapshot
Table 101. Pfizer Inc.: Business Segmentation
Table 102. Pfizer Inc.: Product Portfolio
Table 103. Pfizer Inc.: Revenue, 2018-2020, $ bn
Table 104. Pfizer Inc.: Recent Developments
Table 105. Sanofi: Company Snapshot
Table 106. Sanofi: Business Segmentation
Table 107. Sanofi: Revenue, 2018-2020, $ bn
Table 108. Takeda Pharmaceutical Co. Ltd.: Company Snapshot
Table 109. Risk Evaluation for Investing in Global Market, 2020-2026
Table 110. Critical Success Factors and Key Takeaways
List of Figures
Figure 1. Research Method Flow Chart
Figure 2. Bottom-up Approach and Top-down Approach for Market Estimation
Figure 3. Global Market Forecast in Optimistic, Conservative and Balanced Perspectives, 2020-2026
Figure 4. Global Preventive Vaccines Market, 2016-2026, $ mn
Figure 5. Development Stages of Preventive Vaccines
Figure 6. Impact of COVID-19 on Business
Figure 7. Primary Drivers and Impact Factors of Global Preventive Vaccines Market
Figure 8. Primary Restraints and Impact Factors of Global Preventive Vaccines Market
Figure 9. Investment Opportunity Analysis
Figure 10. Porter’s Five Forces Analysis of Global Preventive Vaccines Market
Figure 11. Breakdown of Global Preventive Vaccines Market by Vaccine Type, 2020-2026, % of Revenue
Figure 12. Contribution to Global 2021-2026 Cumulative Revenue by Vaccine Type, Value ($ mn) and Share (%)
Figure 13. Global Preventive Vaccines Market: Live/Attenuated Vaccines, 2016-2026, $ mn
Figure 14. Global Preventive Vaccines Market: Inactivated Vaccines, 2016-2026, $ mn
Figure 15. Global Preventive Vaccines Market: Subunit Vaccines, 2016-2026, $ mn
Figure 16. Global Preventive Vaccines Market: Toxoid Vaccines, 2016-2026, $ mn
Figure 17. Global Preventive Vaccines Market: Conjugate Vaccines, 2016-2026, $ mn
Figure 18. Global Preventive Vaccines Market: Recombinant Vector Vaccines, 2016-2026, $ mn
Figure 19. Global Preventive Vaccines Market: Other Vaccines, 2016-2026, $ mn
Figure 20. Breakdown of Global Preventive Vaccines Market by Disease, 2020-2026, % of Revenue
Figure 21. Contribution to Global 2021-2026 Cumulative Revenue by Disease, Value ($ mn) and Share (%)
Figure 22. Global Preventive Vaccines Market: Vaccines for Pneumococcal Disease, 2016-2026, $ mn
Figure 23. Global Preventive Vaccines Market: Vaccines for Poliovirus, 2016-2026, $ mn
Figure 24. Global Preventive Vaccines Market: Vaccines for Hepatitis, 2016-2026, $ mn
Figure 25. Global Preventive Vaccines Market: Vaccines for Influenza, 2016-2026, $ mn
Figure 26. Global Preventive Vaccines Market: Vaccines for Measles, Mumps, and Rubella (MMR), 2016-2026, $ mn
Figure 27. Global Preventive Vaccines Market: Vaccines for Varicella, 2016-2026, $ mn
Figure 28. Global Preventive Vaccines Market: Vaccines for Human Papilloma Virus, 2016-2026, $ mn
Figure 29. Global Preventive Vaccines Market: Vaccines for COVID-19, 2016-2026, $ mn
Figure 30. Global Preventive Vaccines Market: Vaccines for Other Diseases, 2016-2026, $ mn
Figure 31. Breakdown of Global Preventive Vaccines Market by Administration, 2020-2026, % of Revenue
Figure 32. Contribution to Global 2021-2026 Cumulative Revenue by Administration, Value ($ mn) and Share (%)
Figure 33. Global Preventive Vaccines Market: Intramuscular Route, 2016-2026, $ mn
Figure 34. Global Preventive Vaccines Market: Subcutaneous Route, 2016-2026, $ mn
Figure 35. Global Preventive Vaccines Market: Oral Route, 2016-2026, $ mn
Figure 36. Global Preventive Vaccines Market: Intravenous Injection, 2016-2026, $ mn
Figure 37. Global Preventive Vaccines Market: Other Administration Routes, 2016-2026, $ mn
Figure 38. Breakdown of Global Preventive Vaccines Market by Patient, 2020-2026, % of Revenue
Figure 39. Contribution to Global 2021-2026 Cumulative Revenue by Patient, Value ($ mn) and Share (%)
Figure 40. Global Preventive Vaccines Market: Pediatric Vaccines, 2016-2026, $ mn
Figure 41. Global Preventive Vaccines Market: Adult Vaccines, 2016-2026, $ mn
Figure 42. Global Market Snapshot by Region
Figure 43. Geographic Spread of Worldwide Preventive Vaccines Market, 2020-2026, % of Revenue
Figure 44. Contribution to Global 2021-2026 Cumulative Revenue by Region, Value ($ mn) and Share (%)
Figure 45. North American Preventive Vaccines Market, 2016-2026, $ mn
Figure 46. Breakdown of North America Preventive Vaccines Market by Country, 2020 and 2026, % of Revenue
Figure 47. Contribution to North America 2021-2026 Cumulative Revenue by Country, Value ($ mn) and Share (%)
Figure 48. U.S. Preventive Vaccines Market, 2016-2026, $ mn
Figure 49. Canada Preventive Vaccines Market, 2016-2026, $ mn
Figure 50. Preventive Vaccines Market in Mexico, 2016-2026, $ mn
Figure 51. European Preventive Vaccines Market, 2016-2026, $ mn
Figure 52. Breakdown of European Preventive Vaccines Market by Country, 2020 and 2026, % of Revenue
Figure 53. Contribution to Europe 2021-2026 Cumulative Revenue by Country, Value ($ mn) and Share (%)
Figure 54. Preventive Vaccines Market in UK, 2016-2026, $ mn
Figure 55. Preventive Vaccines Market in France, 2016-2026, $ mn
Figure 56. Preventive Vaccines Market in Germany, 2016-2026, $ mn
Figure 57. Preventive Vaccines Market in Spain, 2016-2026, $ mn
Figure 58. Preventive Vaccines Market in Italy, 2016-2026, $ mn
Figure 59. Preventive Vaccines Market in Russia, 2016-2026, $ mn
Figure 60. Preventive Vaccines Market in Rest of Europe, 2016-2026, $ mn
Figure 61. Asia-Pacific Preventive Vaccines Market, 2016-2026, $ mn
Figure 62. Breakdown of APAC Preventive Vaccines Market by Country, 2020 and 2026, % of Revenue
Figure 63. Contribution to APAC 2021-2026 Cumulative Revenue by Country, Value ($ mn) and Share (%)
Figure 64. Preventive Vaccines Market in China, 2016-2026, $ mn
Figure 65. Preventive Vaccines Market in Japan, 2016-2026, $ mn
Figure 66. Preventive Vaccines Market in India, 2016-2026, $ mn
Figure 67. Preventive Vaccines Market in Australia, 2016-2026, $ mn
Figure 68. Preventive Vaccines Market in South Korea, 2016-2026, $ mn
Figure 69. Preventive Vaccines Market in Rest of APAC, 2016-2026, $ mn
Figure 70. South America Preventive Vaccines Market, 2016-2026, $ mn
Figure 71. Breakdown of South America Preventive Vaccines Market by Country, 2020 and 2026, % of Revenue
Figure 72. Contribution to South America 2021-2026 Cumulative Revenue by Country, Value ($ mn) and Share (%)
Figure 73. Preventive Vaccines Market in Argentina, 2016-2026, $ mn
Figure 74. Preventive Vaccines Market in Brazil, 2016-2026, $ mn
Figure 75. Preventive Vaccines Market in Colombia, 2016-2026, $ mn
Figure 76. Preventive Vaccines Market in Rest of South America, 2016-2026, $ mn
Figure 77. Preventive Vaccines Market in Middle East and Africa (MEA), 2016-2026, $ mn
Figure 78. Breakdown of MEA Preventive Vaccines Market by Country, 2020 and 2026, % of Revenue
Figure 79. Contribution to MEA 2021-2026 Cumulative Revenue by Country, Value ($ mn) and Share (%)
Figure 80. Preventive Vaccines Market in UAE, 2016-2026, $ mn
Figure 81. Preventive Vaccines Market in Saudi Arabia, 2016-2026, $ mn
Figure 82. Preventive Vaccines Market in Egypt, 2016-2026, $ mn
Figure 83. Growth Stage of Global Preventive Vaccines Industry over the Forecast Period
Figure 84. Top Products of AstraZeneca Based on Revenue from 2016 to 2019 (in million U.S. dollars)
Note: Product cover images may vary from those shown
  • AstraZeneca plc
  • Bavarian Nordic A/S
  • China National Biotec Group Company Ltd.
  • CSL Ltd.
  • Daiichi Sankyo Co. Ltd
  • Emergent BioSolutions Inc.
  • GlaxoSmithKline plc
  • Johnson & Johnson
  • Merck & Co.
  • Moderna Inc.
  • Novavax, Inc.
  • Pfizer Inc.
  • Sanofi SA
  • Takeda Pharmaceutical Co. Ltd.
Note: Product cover images may vary from those shown

Loading
LOADING...